Patterns of Locoregional Failure After Exclusive IMRT for Oropharyngeal Carcinoma

Giuseppe Sanguineti, G. Brandon Gunn, Eugene J. Endres, Gregory Chaljub, Praveena Cheruvu, Brent Parker

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Purpose: To assess the patterns of failure after intensity-modulated radiotherapy (IMRT) for oropharyngeal squamous cell carcinoma (SCC). Methods and Materials: We analyzed patients treated at the University of Texas Medical Branch between May 2002 and February 2006 who met the following criteria: (1) definitive IMRT without chemotherapy for oropharyngeal SCC; (2) no pretreatment radical surgery; (3) minimal follow-up of 1 year. The location of each nodal/primary failure was co-registered to the pretreatment planning computed tomography scan and then expanded by 5 mm to a planning target volume (PTV) of the failure (PTV-f). We then investigated whether the prescription dose to the PTV-f had been appropriate for the amount of disease present before treatment and whether the PTV-f had been adequately covered. Results: A total of 50 patients were eligible. With a median follow-up of 32.6 months (range, 12.1-58.6), three local and six regional failures were observed in 8 patients. All but one failure, that had been neglected, were recorded within 14 months of the treatment end. Of the nine failures, four developed in the neck treated electively to the lowest dose level; in all of them, we could retrospectively identify initial positive lymph nodes that might have justified the subsequent failure. The remaining five failures developed in proximity of the high-dose volume. In all but one, the volume of region of interest receiving ≥95% of the dose of the PTV-f was >95%, suggesting adequate coverage. In 1 patient, about 20% of PTV-f was outside the 95% isodose, so that marginal underdosing could not be ruled out. Conclusions: A potential cause could be identified in all the failures in the lowest dose level. The implications and possible remedies are discussed. Most failures around the high-dose region were "true failures" with no apparent technical cause.

Original languageEnglish (US)
Pages (from-to)737-746
Number of pages10
JournalInternational Journal of Radiation Oncology Biology Physics
Volume72
Issue number3
DOIs
StatePublished - Nov 1 2008

Fingerprint

Intensity-Modulated Radiotherapy
radiation therapy
cancer
Carcinoma
planning
Squamous Cell Carcinoma
dosage
Prescriptions
Neck
Lymph Nodes
Tomography
pretreatment
Drug Therapy
Therapeutics
lymphatic system
causes
chemotherapy
surgery
proximity
tomography

Keywords

  • IMRT
  • Intensity-modulated radiotherapy
  • Oropharyngeal cancer
  • Pattern of failure

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation
  • Cancer Research

Cite this

Patterns of Locoregional Failure After Exclusive IMRT for Oropharyngeal Carcinoma. / Sanguineti, Giuseppe; Gunn, G. Brandon; Endres, Eugene J.; Chaljub, Gregory; Cheruvu, Praveena; Parker, Brent.

In: International Journal of Radiation Oncology Biology Physics, Vol. 72, No. 3, 01.11.2008, p. 737-746.

Research output: Contribution to journalArticle

Sanguineti, Giuseppe ; Gunn, G. Brandon ; Endres, Eugene J. ; Chaljub, Gregory ; Cheruvu, Praveena ; Parker, Brent. / Patterns of Locoregional Failure After Exclusive IMRT for Oropharyngeal Carcinoma. In: International Journal of Radiation Oncology Biology Physics. 2008 ; Vol. 72, No. 3. pp. 737-746.
@article{db7b3df5cea04e5a95ef81ce43760c32,
title = "Patterns of Locoregional Failure After Exclusive IMRT for Oropharyngeal Carcinoma",
abstract = "Purpose: To assess the patterns of failure after intensity-modulated radiotherapy (IMRT) for oropharyngeal squamous cell carcinoma (SCC). Methods and Materials: We analyzed patients treated at the University of Texas Medical Branch between May 2002 and February 2006 who met the following criteria: (1) definitive IMRT without chemotherapy for oropharyngeal SCC; (2) no pretreatment radical surgery; (3) minimal follow-up of 1 year. The location of each nodal/primary failure was co-registered to the pretreatment planning computed tomography scan and then expanded by 5 mm to a planning target volume (PTV) of the failure (PTV-f). We then investigated whether the prescription dose to the PTV-f had been appropriate for the amount of disease present before treatment and whether the PTV-f had been adequately covered. Results: A total of 50 patients were eligible. With a median follow-up of 32.6 months (range, 12.1-58.6), three local and six regional failures were observed in 8 patients. All but one failure, that had been neglected, were recorded within 14 months of the treatment end. Of the nine failures, four developed in the neck treated electively to the lowest dose level; in all of them, we could retrospectively identify initial positive lymph nodes that might have justified the subsequent failure. The remaining five failures developed in proximity of the high-dose volume. In all but one, the volume of region of interest receiving ≥95{\%} of the dose of the PTV-f was >95{\%}, suggesting adequate coverage. In 1 patient, about 20{\%} of PTV-f was outside the 95{\%} isodose, so that marginal underdosing could not be ruled out. Conclusions: A potential cause could be identified in all the failures in the lowest dose level. The implications and possible remedies are discussed. Most failures around the high-dose region were {"}true failures{"} with no apparent technical cause.",
keywords = "IMRT, Intensity-modulated radiotherapy, Oropharyngeal cancer, Pattern of failure",
author = "Giuseppe Sanguineti and Gunn, {G. Brandon} and Endres, {Eugene J.} and Gregory Chaljub and Praveena Cheruvu and Brent Parker",
year = "2008",
month = "11",
day = "1",
doi = "10.1016/j.ijrobp.2008.01.027",
language = "English (US)",
volume = "72",
pages = "737--746",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Patterns of Locoregional Failure After Exclusive IMRT for Oropharyngeal Carcinoma

AU - Sanguineti, Giuseppe

AU - Gunn, G. Brandon

AU - Endres, Eugene J.

AU - Chaljub, Gregory

AU - Cheruvu, Praveena

AU - Parker, Brent

PY - 2008/11/1

Y1 - 2008/11/1

N2 - Purpose: To assess the patterns of failure after intensity-modulated radiotherapy (IMRT) for oropharyngeal squamous cell carcinoma (SCC). Methods and Materials: We analyzed patients treated at the University of Texas Medical Branch between May 2002 and February 2006 who met the following criteria: (1) definitive IMRT without chemotherapy for oropharyngeal SCC; (2) no pretreatment radical surgery; (3) minimal follow-up of 1 year. The location of each nodal/primary failure was co-registered to the pretreatment planning computed tomography scan and then expanded by 5 mm to a planning target volume (PTV) of the failure (PTV-f). We then investigated whether the prescription dose to the PTV-f had been appropriate for the amount of disease present before treatment and whether the PTV-f had been adequately covered. Results: A total of 50 patients were eligible. With a median follow-up of 32.6 months (range, 12.1-58.6), three local and six regional failures were observed in 8 patients. All but one failure, that had been neglected, were recorded within 14 months of the treatment end. Of the nine failures, four developed in the neck treated electively to the lowest dose level; in all of them, we could retrospectively identify initial positive lymph nodes that might have justified the subsequent failure. The remaining five failures developed in proximity of the high-dose volume. In all but one, the volume of region of interest receiving ≥95% of the dose of the PTV-f was >95%, suggesting adequate coverage. In 1 patient, about 20% of PTV-f was outside the 95% isodose, so that marginal underdosing could not be ruled out. Conclusions: A potential cause could be identified in all the failures in the lowest dose level. The implications and possible remedies are discussed. Most failures around the high-dose region were "true failures" with no apparent technical cause.

AB - Purpose: To assess the patterns of failure after intensity-modulated radiotherapy (IMRT) for oropharyngeal squamous cell carcinoma (SCC). Methods and Materials: We analyzed patients treated at the University of Texas Medical Branch between May 2002 and February 2006 who met the following criteria: (1) definitive IMRT without chemotherapy for oropharyngeal SCC; (2) no pretreatment radical surgery; (3) minimal follow-up of 1 year. The location of each nodal/primary failure was co-registered to the pretreatment planning computed tomography scan and then expanded by 5 mm to a planning target volume (PTV) of the failure (PTV-f). We then investigated whether the prescription dose to the PTV-f had been appropriate for the amount of disease present before treatment and whether the PTV-f had been adequately covered. Results: A total of 50 patients were eligible. With a median follow-up of 32.6 months (range, 12.1-58.6), three local and six regional failures were observed in 8 patients. All but one failure, that had been neglected, were recorded within 14 months of the treatment end. Of the nine failures, four developed in the neck treated electively to the lowest dose level; in all of them, we could retrospectively identify initial positive lymph nodes that might have justified the subsequent failure. The remaining five failures developed in proximity of the high-dose volume. In all but one, the volume of region of interest receiving ≥95% of the dose of the PTV-f was >95%, suggesting adequate coverage. In 1 patient, about 20% of PTV-f was outside the 95% isodose, so that marginal underdosing could not be ruled out. Conclusions: A potential cause could be identified in all the failures in the lowest dose level. The implications and possible remedies are discussed. Most failures around the high-dose region were "true failures" with no apparent technical cause.

KW - IMRT

KW - Intensity-modulated radiotherapy

KW - Oropharyngeal cancer

KW - Pattern of failure

UR - http://www.scopus.com/inward/record.url?scp=52949112636&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52949112636&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2008.01.027

DO - 10.1016/j.ijrobp.2008.01.027

M3 - Article

VL - 72

SP - 737

EP - 746

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 3

ER -